Dr Thomas Exner

Dr Thomas Exner

Job Title: 
Chief Scientific Officer (CSO)

Dr Thomas Exner is responsible for the scientific planning, execution and supervision of different commercial project in the area of data management and integrated testing strategy development for risk/safety assessment of chemicals, drugs and nano materials. Additionally, he is coordinating the H2020 e-infrastructure project OpenRiskNet, is work package leader in the ACEnano and NanoCommons project, leads the creation of a knowledge infrastructure in the EU-ToxRisk project as well as functions as principal investigator in the Marie Skłodowska-Curie Innovative Training Network in3.

He studied chemistry and did his PhD in physical chemistry at the Technische Universität Darmstadt. After a postdoctoral stay at the University of Saskatchewan, Canada, he was appointed Assistant Professor at the University of Konstanz in 2003. In April 2012, he moved to the Institute of Pharmacy at the University of Tübingen and continued his research in close co-operation with the experimental and theoretical groups at the Institute until early 2015, when he moved to Douglas Connect.

Dr. Exner is the author and co-author of more than 50 articles in peer reviewed international journals and several other scientific contributions.

Latest Tweets

Edelweiss Connect (3 days ago)
RT @openrisknet: Read about our latest achievements on the federation of computing and data resources between the @OpenRiskNet #einfrastruc…
Edelweiss Connect (2 weeks ago)
RT @EU_ToxRisk: Next week, @EU_ToxRisk workshop open to experts with interest and background into #regulatory science. Focus: regulatory as…
Edelweiss Connect (2 weeks ago)
Our May 2019 newsletter highlights the upcoming @openrisknet webinars, the May 21-22 free training on New Approach… https://t.co/eYqFaD51iA
Edelweiss Connect (3 weeks ago)
Rich metadata for richer results - learn how AI approaches are increasing the need for rich metadata:… https://t.co/Aj68GoQYTI
Edelweiss Connect (4 weeks ago)
RT @barryhardy: Automated & Integrated Workflow for Adverse Outcome Pathway Identification, Hypothesis Generation & Risk Assessment, Webina…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com